Roelofs Nicolas H PHD
CIK: 0001292341
Associated companies
Transaction History
| SEER | ▲ Buy | Grant | 16,500 | $0 | 7/28/2026 | View on chart |
| SEER | ▲ Buy | Grant | 17,083 | $0 | 7/7/2025 | View on chart |
| SEER | ▲ Buy | Grant | 46,886 | $0 | 8/13/2024 | View on chart |
| SEER | ▲ Buy | Grant | 16,500 | $0 | 7/28/2026 | View on chart |
| SEER | ▲ Buy | Grant | 17,083 | $0 | 7/7/2025 | View on chart |
| SEER | ▲ Buy | Grant | 46,886 | $0 | 8/13/2024 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
Seer to Present Proteomics Data at HUPO 2026; CFO Transition Announced
Seer Inc. will share early results from its PRECISE-SG100K proteomics study with Nanyang Technological University at the HUPO 2026 conference. The company also announced a transition in its Chief Financial Officer role. These developments provide updates on the firm's scientific progress and leadership structure.
Seer to Present Proteomics Data at HUPO 2026; CFO Transition Announced. Seer Inc. will share early results from its PRECISE-SG100K proteomics study with Nanyang Technological University at the HUPO 2026 conference. The company also announced a transition in its Chief Financial Officer role. These developments provide updates on the firm's scientific progress and leadership structure.